• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞中的GHSR-Foxo1信号通路通过炎症反应和肝星状细胞激活促进肝纤维化。

GHSR-Foxo1 Signaling in Macrophages Promotes Liver Fibrosis via Inflammatory Response and Hepatic Stellate Cell Activation.

作者信息

Kim Da Mi, Pan Quan, Liu Zeyu, Ai Weiqi, Han Hye Won, Banu Sakhila K, Tsai Robert Y L, Wright Gus A, Guo Shaodong, Sun Yuxiang

机构信息

Department of Nutrition, Texas A&M University, College Station, TX, 77843, USA.

Department of Veterinary Pathobiology, Texas A&M University, College Station, TX, 77843, USA.

出版信息

Adv Sci (Weinh). 2025 Sep;12(33):e04223. doi: 10.1002/advs.202504223. Epub 2025 Jun 6.

DOI:10.1002/advs.202504223
PMID:40479577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12412619/
Abstract

Liver fibrosis is a severe liver disease directly linked to chronic inflammation, in which hepatic macrophages play a key role. Growth hormone secretagogue receptor (GHSR) is the receptor of nutrient-sensing hormone ghrelin that has essential functions in metabolism, inflammation, and wound-healing. However, the role of GHSR in liver fibrosis is unknown. This study uses a carbon tetrachloride (CCl)-induced liver fibrosis mouse model to investigate the role of macrophage GHSR in liver fibrosis. CCl induces macrophage accumulation and inflammatory responses, noticeably increases GHSR expression in the liver. It is found that macrophage Ghsr deletion (Ghsr-MϕKO) attenuates CCl-induced liver fibrosis and inflammation, showing reduced hepatic monocyte-derived macrophages (MDMs) and suppressed proinflammatory responses. In macrophages, transforming growth factor (TGF)-β1 expression is positively correlated with GHSR expression. GHSR-associated TGF-β1 in macrophages activates hepatic stellate cells (HSCs) by promoting the crosstalk between macrophages and HSCs. Macrophage GHSR controls inflammation and TGF-β1 expression via protein kinase A (PKA)-mediated Forkhead box protein O 1 (Foxo1) phosphorylation at S273; Foxo1-S273D mutation, mimicking constitutive phosphorylation of Foxo1 at S273, shows exacerbated CCl-induced liver inflammation and fibrosis. Thus, targeting the macrophage GHSR-Foxo1 signaling may provide a new strategy to treat liver fibrosis.

摘要

肝纤维化是一种与慢性炎症直接相关的严重肝脏疾病,其中肝巨噬细胞起着关键作用。生长激素促分泌素受体(GHSR)是营养感应激素胃饥饿素的受体,在代谢、炎症和伤口愈合中具有重要功能。然而,GHSR在肝纤维化中的作用尚不清楚。本研究使用四氯化碳(CCl)诱导的肝纤维化小鼠模型来研究巨噬细胞GHSR在肝纤维化中的作用。CCl诱导巨噬细胞积聚和炎症反应,显著增加肝脏中GHSR的表达。研究发现,巨噬细胞Ghsr基因缺失(Ghsr-MϕKO)可减轻CCl诱导的肝纤维化和炎症,表现为肝脏单核细胞衍生巨噬细胞(MDM)减少和促炎反应受到抑制。在巨噬细胞中,转化生长因子(TGF)-β1的表达与GHSR的表达呈正相关。巨噬细胞中与GHSR相关的TGF-β1通过促进巨噬细胞与肝星状细胞(HSC)之间的相互作用来激活HSC。巨噬细胞GHSR通过蛋白激酶A(PKA)介导的叉头框蛋白O 1(Foxo1)在S273位点的磷酸化来控制炎症和TGF-β1的表达;Foxo1-S273D突变模拟了Foxo1在S273位点的组成型磷酸化,显示CCl诱导的肝脏炎症和纤维化加剧。因此,靶向巨噬细胞GHSR-Foxo1信号通路可能为治疗肝纤维化提供一种新策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2075/12412619/2496464475c8/ADVS-12-e04223-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2075/12412619/4820a5e99076/ADVS-12-e04223-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2075/12412619/c6288f34e980/ADVS-12-e04223-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2075/12412619/85294e3252e3/ADVS-12-e04223-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2075/12412619/a4c780d906ab/ADVS-12-e04223-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2075/12412619/dd17d8fdc885/ADVS-12-e04223-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2075/12412619/2496464475c8/ADVS-12-e04223-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2075/12412619/4820a5e99076/ADVS-12-e04223-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2075/12412619/c6288f34e980/ADVS-12-e04223-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2075/12412619/85294e3252e3/ADVS-12-e04223-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2075/12412619/a4c780d906ab/ADVS-12-e04223-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2075/12412619/dd17d8fdc885/ADVS-12-e04223-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2075/12412619/2496464475c8/ADVS-12-e04223-g003.jpg

相似文献

1
GHSR-Foxo1 Signaling in Macrophages Promotes Liver Fibrosis via Inflammatory Response and Hepatic Stellate Cell Activation.巨噬细胞中的GHSR-Foxo1信号通路通过炎症反应和肝星状细胞激活促进肝纤维化。
Adv Sci (Weinh). 2025 Sep;12(33):e04223. doi: 10.1002/advs.202504223. Epub 2025 Jun 6.
2
HBHP ameliorates CCL4-induced liver fibrosis in rats by inhibiting HMGB1-mediated inflammatory response through binding to the HMGB1-A box.HBHP通过与HMGB1的A盒结合抑制HMGB1介导的炎症反应,从而改善大鼠四氯化碳诱导的肝纤维化。
Eur J Pharmacol. 2025 Oct 5;1004:177971. doi: 10.1016/j.ejphar.2025.177971. Epub 2025 Jul 17.
3
Medium-Chain Fatty Acids Ameliorate Liver Fibrosis by Phosphorylating Hepatic Stellate Cell Forkhead Box Protein O1.中链脂肪酸通过磷酸化肝星状细胞叉头框蛋白O1改善肝纤维化。
Liver Int. 2025 Sep;45(9):e70270. doi: 10.1111/liv.70270.
4
Vitamin D receptor attenuates carbon tetrachloride-induced liver fibrosis via downregulation of YAP.维生素 D 受体通过下调 YAP 减轻四氯化碳诱导的肝纤维化。
J Hazard Mater. 2024 Oct 5;478:135480. doi: 10.1016/j.jhazmat.2024.135480. Epub 2024 Aug 10.
5
Leonurine Attenuates CCl-Induced Hepatic Fibrosis in Mice via the Hippo-YAP Pathway.益母草碱通过Hippo-YAP信号通路减轻CCl诱导的小鼠肝纤维化
Drug Des Devel Ther. 2025 Jul 30;19:6553-6571. doi: 10.2147/DDDT.S518793. eCollection 2025.
6
The Foxo1-YAP-Notch1 axis reprograms STING-mediated innate immunity in NASH progression.Foxo1-YAP-Notch1 轴在 NASH 进展中重新编程 STING 介导的固有免疫。
Exp Mol Med. 2024 Aug;56(8):1843-1855. doi: 10.1038/s12276-024-01280-5. Epub 2024 Aug 9.
7
The Non-Canonical ChREBPα Activity Suppresses the Activation of Hepatic Stellate Cells and Liver Fibrosis by Antagonizing TGF-β-E2F1 Axis.非经典ChREBPα活性通过拮抗TGF-β-E2F1轴抑制肝星状细胞激活和肝纤维化。
Adv Sci (Weinh). 2025 Aug;12(29):e15032. doi: 10.1002/advs.202415032. Epub 2025 Jun 23.
8
Amelioration of Liver Fibrosis via In Situ Hepatic Stellate Cell Conversion Through Co-Inhibition of TGF-β and GSK-3 Signalling.通过共抑制转化生长因子-β(TGF-β)和糖原合成酶激酶-3(GSK-3)信号通路原位诱导肝星状细胞转化改善肝纤维化
Liver Int. 2025 Jul;45(7):e70187. doi: 10.1111/liv.70187.
9
Endothelial Tgfbr2 Deficiency Ameliorate Liver Fibrosis Through Regulating Angiocrine Signalling and Macrophage Accumulation.内皮细胞Tgfbr2缺乏通过调节血管分泌信号和巨噬细胞积聚改善肝纤维化。
Liver Int. 2025 Sep;45(9):e70227. doi: 10.1111/liv.70227.
10
Design and synthesis of genipine derivatives for the treatment of liver fibrosis by modulating TGF-β1/Smad signaling pathway.通过调节TGF-β1/Smad信号通路设计与合成用于治疗肝纤维化的京尼平衍生物
Eur J Med Chem. 2025 Oct 15;296:117869. doi: 10.1016/j.ejmech.2025.117869. Epub 2025 Jun 15.

引用本文的文献

1
Inflammatory factor CCL2 enhances the interaction between monocyte-macrophage cells and liver parenchymal cells to promote liver inflammation and fibrosis in biliary atresia.炎症因子CCL2增强单核巨噬细胞与肝实质细胞之间的相互作用,以促进胆道闭锁中的肝脏炎症和纤维化。
BMC Pediatr. 2025 Aug 23;25(1):643. doi: 10.1186/s12887-025-05984-z.

本文引用的文献

1
Immunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy.肝纤维化的免疫调节:抗纤维化治疗的新机遇
Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):281-299. doi: 10.1146/annurev-pharmtox-020524-012013. Epub 2024 Dec 17.
2
The Foxo1-YAP-Notch1 axis reprograms STING-mediated innate immunity in NASH progression.Foxo1-YAP-Notch1 轴在 NASH 进展中重新编程 STING 介导的固有免疫。
Exp Mol Med. 2024 Aug;56(8):1843-1855. doi: 10.1038/s12276-024-01280-5. Epub 2024 Aug 9.
3
Ghrelin regulating liver activity and its potential effects on liver fibrosis and .
生长激素释放肽调节肝脏活性及其对肝纤维化和的潜在影响。
Front Cell Infect Microbiol. 2024 Jan 8;13:1324134. doi: 10.3389/fcimb.2023.1324134. eCollection 2023.
4
Nutrient-sensing growth hormone secretagogue receptor in macrophage programming and meta-inflammation.巨噬细胞编程和代谢性炎症中的营养感应生长激素促分泌素受体
Mol Metab. 2024 Jan;79:101852. doi: 10.1016/j.molmet.2023.101852. Epub 2023 Dec 12.
5
Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammation and TGF-β1-mediated HSC Activation.肝细胞 FoxO1 缺乏通过减少炎症和 TGF-β1 介导的 HSC 活化来保护肝脏纤维化。
Cell Mol Gastroenterol Hepatol. 2024;17(1):41-58. doi: 10.1016/j.jcmgh.2023.08.013. Epub 2023 Sep 9.
6
Suppression of FOXO1 attenuates inflamm-aging and improves liver function during aging.抑制 FOXO1 可减轻衰老过程中的炎症性衰老并改善肝功能。
Aging Cell. 2023 Oct;22(10):e13968. doi: 10.1111/acel.13968. Epub 2023 Aug 21.
7
Nutrient-Sensing Ghrelin Receptor in Macrophages Modulates Bisphenol A-Induced Intestinal Inflammation in Mice.巨噬细胞中感应营养素的生长激素释放肽受体可调节双酚 A 诱导的小鼠肠道炎症。
Genes (Basel). 2023 Jul 16;14(7):1455. doi: 10.3390/genes14071455.
8
Hepatic inflammatory responses in liver fibrosis.肝纤维化中的肝脏炎症反应。
Nat Rev Gastroenterol Hepatol. 2023 Oct;20(10):633-646. doi: 10.1038/s41575-023-00807-x. Epub 2023 Jul 3.
9
Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease.肥胖相关非酒精性脂肪性肝病中生长激素释放肽和 LEAP-2 对肝星状细胞激活和肝纤维化的拮抗作用。
Eur J Endocrinol. 2023 Jul 10;188(7):564-577. doi: 10.1093/ejendo/lvad071.
10
Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure.肝 TGF-β1 和 Foxo1 的相互调控控制糖异生和能量消耗。
Diabetes. 2023 Sep 1;72(9):1193-1206. doi: 10.2337/db23-0180.